| Title |
Modified Date |
| RPA Comments on the 2025 Medicare Fee Schedule Proposed Rule | September 9, 2024 |
| RPA Comments on the 2025 ESRD Prospective Payment System Proposed Rule | August 23, 2024 |
| RPA Comments on IOTA Transplant Payment Model Proposed Rule | July 22, 2024 |
| Transplant Community Letter to DOT on FAA Reauthorization and Organ Transportation | June 25, 2024 |
| RPA, Organized Medicine Letter on New CEHRT Requirements | April 16, 2024 |
| RPA, ASN Letter to HHS/CMS on Use of the RTA in the CKCC Models | April 2, 2024 |
| RPA Comments on the 2025 Medicare Advantage Advance Notice | March 1, 2024 |
| RPA Organized Medicine Letter to the Veterans Administration on the National Standards of Practice Process | February 26, 2024 |
| RPA Comments on the 2024 Medicare Fee Schedule Proposed Rule | September 11, 2023 |
| RPA Comments on 2024 ESRD Prospective Payment System Proposed Rule | August 16, 2023 |
| RPA Kidney Community Letter on Strengthening the U.S. Transplantation System | May 2, 2023 |
| RPA Organized Medicine Recommendations to CMS on MIPS MVPs | March 6, 2023 |
| RPA Comments on MA Advance Notice and Potential Impact on CKCC Models | March 6, 2023 |
| RPA Organized Medicine Letter to CMS on Prior Authorization Proposed Rule | February 23, 2023 |
| RPA Comments on Proposed Revisions to CMS-2728 ESRD Medical Evidence Form | February 13, 2023 |
| RPA Comments on ABIM Procedural Requirements for Initial Certification | October 18, 2022 |
| RPA AMR Coalition Letter to Secretary Becerra on Promotion of the Pasteur Act | October 11, 2022 |
| RPA Comments on the 2023 HOPPS/ASC Proposed Rule |
September 12, 2022 |
| RPA Comments on the 2023 Medicare Fee Schedule Proposed Rule |
September 6, 2022 |
| RPA Comments on 2023 ESRD Prospective Payment System Proposed Rule |
August 23, 2022 |
| RPA In-Office Procedures Community Letter to MedPAC on Site-Neutral Payments |
August 15, 2022 |
| RPA Comments on Immunosuppressive Drug Coverage Proposed Rule |
June, 27, 2022 |
| RPA Organized Medicine Sign-On Letter on Appropriate Use Criteria |
May 20, 2022 |
| RPA Organized Medicine Sign-On Letter on Split/Shared Services |
April 4, 2022 |
| RPA Organized Medicine Letter on Reopening of the PRF Reporting Period |
April 4, 2022 |
| RPA/Internal Medicine Sign On Letter on Split/Shared Services |
March 29, 2022 |
| RPA Response to CMS RFI |
February 1, 2022 |
| RPA Support for Kidney Emoji |
January 3, 2022 |
RPA Comments on the 2022 Medicare Fee Schedule Proposed Rule
|
September 13, 2021 |
RPA/Vascular Access Community Sign On Letter on Clinical Labor Pricing
|
September 13, 2021 |
RPA Comments on the 2022 HOPPS/ASC Proposed Rule
|
September 13, 2021 |
| RPA Sign-On Coalition Letter on Proposed Fee Schedule Revision to Clinical Labor Pricing
|
September 7, 2021 |
| RPA Comments on 2022 ESRD PPS Proposed Rule, including ETC provisions |
August 31. 2021 |
| RPA Sign-On Letter with Organized Medicine on VA Supremacy Project IFR |
August 2, 2021 |
RPA Response to CMMI Delay of KCC Payment Models
|
March 11, 2021 |
RPA Highlights Priority Issues to Biden Administration
|
March 9, 2021 |
RPA Sing-On Letter with Kidney Community on Prioritization of Dialysis Patients and Staff for COVID Vaccinations
|
February 25, 2021 |
RPA Sign-On Letter with the Kidney Community to Biden Administration on Kidney-Related Health Policy Priorities
|
February 2, 2021 |
RPA-ASPN-ASN Letter on Pediatric Care in the ETC Model
|
November 10, 2020 |
RPA Comments on the 2021 HOPPS/ASC Proposed Rule
|
October 5, 2020 |
RPA Comments on the 2021 Medicare Fee Schedule Proposed Rule
|
October 5, 2020 |
RPA Comments on 2021 ESRD PPS Proposed Rule
|
September 4, 2020 |
| RPA Letter to CMS on Coverage for Innovative Placement of Central Venous Catheters |
August 25, 2020 |
RPA Comments on Local Coverage Determinations on Percutaneous AV Fistulas
|
June 30, 2020 |
RPA Comments on the CMS Interim Final Rule: Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
|
June 1, 2020 |
RPA Input on Implementation of Kidney Payment Models
|
April 20, 2020 |
Alliance for Home Dialysis Request that Home Dialysis Training Services Be Approved for Telehealth
|
April 8, 2020 |
| RPA Sign-on Letter to CMS on Payment Concerns Regarding Telephone Calls |
April 8, 2020 |
AMA sign on letter to HHS Secretary for Emergency Funding for Physician Practices
|
April 7, 2020 |
| RPA Sign-On Letter with Home Dialysis Community Requesting COVID-19 Waivers |
March 23, 2020 |
| RPA Comments on CMS Proposed Rule on Organ Procurement Organizations Conditions for Coverage |
February 21, 2020 |
| RPA Comments on HRSA Proposed Rule on Removing Financial Disincentives to Living Organ Donation |
February 18, 2020 |
| RPA Comments on AHRQ Report on Frequency and Duration of Dialysis |
January 2, 2020 |
| RPA Comments on the 2020 Medicare Fee Schedule Final Rule |
December 31, 2019 |
| RPA Comments on the 2020 HOPPS/ASC Final Rule |
December 31, 2019 |
| RPA Comments on the OIG Proposed Rule on the Anti-Kickback Statute |
December 31, 2019 |
RPA Input on Kidney Care First Request for Applications
|
December 9, 2019 |
| RPA Comments on 2020 Medicare Fee Schedule Proposed Rule |
September 27, 2019 |
RPA Comments on 2020 ESRD PPS Proposed Rule
|
September 27, 2019 |
RPA Comments on 2020 ASC Proposed Rule
|
September 27, 2019 |
RPA Comments on ESRD Treatment Choices Proposed Rule
|
September 16, 2019 |
| RPA Comments on CMS' Patients Over Paperwork Request for Information |
August 12, 2019 |
| RPA Sign-On Letter Surprise Billing |
July 16, 2019 |
| Summary of Presidential Executive Order on Kidney Disease & Proposed Kidney Care Payment Models |
July 10, 2019 |
| RPA Comments to ONC on 21st Century Cures Act |
June 3, 2019 |
| RPA Comments to CMS on Interoperability Proposed Rule |
June 3, 2019 |
RPA Sign On Letter with Kidney Community on Transitional Add-on Payments for ESRD Innovation
|
May 17, 2019 |
RPA Letter to CMS on Ambulatory Surgical Center (ASC) on Vascular Access Ambulatory Payment Classifications (APCs)
|
March 8, 2019 |
RPA Sign-on Letter with AMA on Use of Prior Authorizations in Medicare Advantage
|
February 28, 2019 |
RPA Comments to CMS on 2020 Medicare Part D Drug Pricing Proposed Rule
|
January 23, 2019 |
Print Page